Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 2006

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Weight gain in obese and nonobese adolescent girls initiating depot

medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive

method.

AUTHORS

Bonny AE; Ziegler J; Harvey R; Debanne SM; Secic M

SOURCE

Archives of Pediatrics and Adolescent Medicine. 2006 Jan;160(1):40-45.

ABSTRACT

The objective was to examine weight changes in a large cohort of obese and nonobese adolescent girls initiating

depot medroxyprogesterone acetate (DMPA), an oral contraceptive (OC), or no hormonal contraceptive method

(control). Prospective study of 450 adolescent girls, aged 12 to 18 years, who attended 4 urban health clinics and

selected DMPA, OC, or control. Data collection occurred at baseline and at 6, 12, and 18 months; consisted of

structured interview and measurement of height and weight; and occurred from April 19, 2000, through September 26,

2003. Weight was examined as mean change over 18 months and actual weight at each study visit. On the basis of

preliminary analyses, we stratified the sample according to baseline obesity status (nonobese, body mass index

[calculated as weight in kilograms divided by the square of height in meters] _30; obese, body mass index < 30).

Adolescent girls who were obese at initiation of DMPA gained significantly more weight than did obese girls starting

OC or control (P_.001 for both). At 18 months, mean weight gain was 9.4, 0.2, and 3.1 kg for obese girls receiving

DMPA, receiving OC, and control, respectively. Weight gain in obese girls receiving DMPA was also greater than

weight gain in all nonobese categories (4.0 kg, DMPA; 2.8 kg, OC; 3.5 kg, control; P < .001). A significant interaction

(P = .006) between length of time receiving DMPA and weight gain was evident for obese subjects. Over 18 months,

DMPA use was associated with increasing rates of weight gain in obese subjects. The potential contribution to

severe obesity in this population is concerning. (PubHealth.info Document ID: CONT1T 48-06)

PubHealth.info NOTE: The author(s) of this article titled, "Weight gain in obese and nonobese adolescent girls

initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method.", is(are) Bonny

AE; Ziegler J; Harvey R; Debanne SM; Secic M. The source of this article is "Archives of Pediatrics and

Adolescent Medicine. 2006 Jan;160(1):40-45.". This article was published in 2006 in English language(s).

(PubHealth.info® Document ID: CONT1T 48-06. All rights reserved with PubHealth.info) PIN: 48

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.